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Nonalcoholic fatty liver disease (NAFLD) and metabolic risk
factors for NAFLD are predominantly diagnosed in adults and
are frequently not suspected nor diagnosed during childhood
and adolescence despite an association with prevalent or future
risk for the metabolic syndrome, nonalcoholic steatohepatitis
(NASH), cirrhosis, type 2 diabetes and atherosclerotic cardio-
vascular disease. Identification of children at increased risk of
future NAFLD, may guide interventions to prevent adolescent
and adult NAFLD and associated metabolic disorders. Objec-
tives and Methods: We sought a relationship between child-
hood anthropometry (including weight, body mass index (BMI),
skinfold thickness (SFT), head circumference (HC), chest cir-
cumference (CC) and arm circumference (AC)) and adolescent
NAFLD in 1170 serially well characterized 17-year-old adoles-
cents participating in the Western Australian Pregnancy Cohort
(Raine Cohort) Study. Case-control analysis was performed
using anthropometric measurements serially recorded from
birth. NAFLD was diagnosed using liver ultrasound at age 17
years. Results: 150/1170 adolescents (12.8%) were diag-
nosed with NAFLD. Neither birth weight nor percentage of
expected birth weight was associated with NAFLD. There were
significant differences in anthropometry acquired during child-
hood between participants subsequently diagnosed with
NAFLD and those without NAFLD. There was a significant mean
(sd) body weight difference of 2.7% at age 3 years (15.3 (1.7)
kg vs. 14.9 (1.8) kg), progressing to a difference of 24.7%
(81.4 (20.5) kg vs. 65.3 (11.5) kg at age 17 years between
those with NAFLD and those without NAFLD (p<0.05 at all
ages). HC was smaller from age 1 year to 5 years while SFT
was greater from age 2 years, BMI and AC from age 3 years
and CC from age 5 years onwards (p<0.05 for all). Boys diag-
nosed with NAFLD at age 17 years had higher systolic blood
pressure than boys without NAFLD from age 10 years
(p<0.05). Apart from HC, all of these differences persisted and
increased through age 17 years. Using multiple logistic regres-
sion analysis adjusted for body weight, BMI, AC and CC up to
age 5 years, greater suprailiac SFT at age 3 years (OR 1.18,
95% CI 1.05-1.33, p=0.006), CC at age 5 years (OR 1.15,
95% CI 1.08-1.24, p<0.001) and smaller HC at age 1 year
(OR 0.65, 95% CI 0.53-0.80, p<0.001) were independent
predictors of adolescent NAFLD. Conclusions: Changes in
growth and adiposity from as early as one year of age are
associated with the future development of NAFLD in 17 year
olds. Anthropometric measurements during early childhood
may identify individuals predestined to develop NAFLD and
allow early targeted intervention.
Disclosures:
John K. Olynyk - Grant/Research Support: Roche, Bayer, Pfizer
The following people have nothing to disclose: Oyekoya T. Ayonrinde, Lawrie J.
Beilin, Trevor A. Mori, Wendy H. Oddy, Leon Adams
466A AASLD ABSTRACTS HEPATOLOGY, October, 2011
